IL-15-IN-1 - 98%, high purity , CAS No.1831830-20-6

Item Number
I412820
Grouped product items
SKUSizeAvailabilityPrice Qty
I412820-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$399.90
I412820-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$699.90
I412820-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$979.90
I412820-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,359.90

Basic Description

Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsIL-15-IN-1 is a potent and selective inhibitor of Interleukin 15 (IL-15) that inhibits the proliferation of IL-15-dependent cells with IC50 of 0.8 μM.
Storage TempProtected from light,Store at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Product Description

Information

IL-15-IN-1 is a potent and selective inhibitor of Interleukin 15 (IL-15) that inhibits the proliferation of IL-15-dependent cells with IC50 of 0.8 μM.

Associated Targets(Human)

IL15 Tchem Interleukin-15 (50 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Il2 Interleukin-2 (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate
INCHI InChI=1S/C30H36N6O4S/c1-4-40-29(39)21-13-12-14-22(19-21)31-27(37)17-8-6-5-7-11-18-41-30-33-32-26(35(30)2)20-25-23-15-9-10-16-24(23)28(38)36(3)34-25/h9-10,12-16,19H,4-8,11,17-18,20H2,1-3H3,(H,31,37)
InChi Key GWNFQAKCJYEJEW-UHFFFAOYSA-N
Canonical SMILES CCOC(=O)C1=CC(=CC=C1)NC(=O)CCCCCCCSC2=NN=C(N2C)CC3=NN(C(=O)C4=CC=CC=C43)C
Isomeric SMILES CCOC(=O)C1=CC(=CC=C1)NC(=O)CCCCCCCSC2=NN=C(N2C)CC3=NN(C(=O)C4=CC=CC=C43)C
PubChem CID 129320517
Molecular Weight 576.71

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

7 results found

Lot NumberCertificate TypeDateItem
B2402201Certificate of AnalysisJan 02, 2024 I412820
B2402202Certificate of AnalysisJan 02, 2024 I412820
B2402203Certificate of AnalysisJan 02, 2024 I412820
B2402204Certificate of AnalysisJan 02, 2024 I412820
B2402205Certificate of AnalysisJan 02, 2024 I412820
B2402206Certificate of AnalysisJan 02, 2024 I412820
B2402207Certificate of AnalysisJan 02, 2024 I412820

Chemical and Physical Properties

SolubilityDMSO: 122 mg/mL (211.55 mM), Need ultrasonic
SensitivityLight sensitive;Heat sensitive

Related Documents

References

1. Mortier E, Quéméner A, Vusio P, Lorenzen I, Boublik Y, Grötzinger J, Plet A, Jacques Y.  (2006)  Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins..  J Biol Chem,  281  (3): (1612-9).  [PMID:16284400] [10.1021/op500134e]
2. Quéméner A, Maillasson M, Arzel L, Sicard B, Vomiandry R, Mortier E, Dubreuil D, Jacques Y, Lebreton J, Mathé-Allainmat M.  (2017)  Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization..  J Med Chem,  60  (14): (6249-6272).  [PMID:28657314] [10.1021/op500134e]

Solution Calculators